<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03481738</url>
  </required_header>
  <id_info>
    <org_study_id>AG348-C-008</org_study_id>
    <nct_id>NCT03481738</nct_id>
  </id_info>
  <brief_title>Pyruvate Kinase Deficiency Global Longitudinal Registry</brief_title>
  <acronym>PEAK Registry</acronym>
  <official_title>Pyruvate Kinase Deficiency Global Longitudinal Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Agios Pharmaceuticals, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Agios Pharmaceuticals, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is an observational (ie, noninterventional), longitudinal, multicenter, global&#xD;
      registry for patients with pyruvate kinase (PK) deficiency, a rare nonspherocytic hemolytic&#xD;
      anemia.&#xD;
&#xD;
      This Registry will be open for enrollment for 7 years and all enrolled participants will be&#xD;
      followed prospectively for a minimum of 2 years, and up to 9 years.&#xD;
&#xD;
      Data will be collected from participating Registry Physicians, participants, and, where&#xD;
      appropriate, parents/guardians who have provided informed consent or assent (where relevant)&#xD;
      and authorization pursuant to applicable laws and regulations.&#xD;
&#xD;
      Data should include demographic, clinical, and treatment data; and other data of relevance to&#xD;
      the management of patients with PK deficiency. Annual chart review and data entry are&#xD;
      expected in order to enhance longitudinal understanding of PK deficiency; however, no&#xD;
      specific protocol schedule of assessment is required by this Registry protocol.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data will be submitted to the Registry via electronic case report forms (eCRFs). Relevant&#xD;
      datasets, such as historical trial data, claims, medical records, or central lab data will be&#xD;
      electronically integrated into the Registry or Registry reporting data sets.&#xD;
&#xD;
      Participants of all ages with a confirmed diagnosis of PK deficiency via genetic testing will&#xD;
      be eligible to participate in this Registry. Diagnosis may be made on the basis of clinical&#xD;
      features consistent with PK deficiency together with the presence of 2 or more PKLR gene&#xD;
      mutations.&#xD;
&#xD;
      For novel or indeterminate PKLR gene mutations, participants will be deemed eligible if, in&#xD;
      the opinion of the investigator, the reported PKLR gene mutations are sufficient to support a&#xD;
      diagnosis of PK deficiency. Pyruvate kinase deficiency-relevant data will be entered by&#xD;
      Registry Physicians or their designee for any and all participant visits. Disease parameters&#xD;
      (eg, hemoglobin, reticulocyte counts), treatment and management options (splenectomy,&#xD;
      transfusions, iron chelation, bone marrow transplant or pharmacological therapies) and&#xD;
      resource utilization (eg, hospitalizations) will be evaluated to describe the natural&#xD;
      history, treatments and outcomes, variability in clinical care and disease burden in patients&#xD;
      with PK deficiency.&#xD;
&#xD;
      As a longitudinal observational study, the PK deficiency Registry may also serve as a data&#xD;
      collection platform to address specific research objectives that may emerge over the duration&#xD;
      of the study.&#xD;
&#xD;
      All data collection efforts will abide by this protocol and be prospectively disclosed in the&#xD;
      Registry informed consent. If new assessments become of interest, they may be addressed via&#xD;
      specific substudies (eg, patient-reported outcomes, biobanking), each requiring their own&#xD;
      specific protocol and consent approved by Institutional Review Broad/Independent Ethics&#xD;
      Committee (IRB/IEC). These studies may utilize a decentralized operational model with remote&#xD;
      data capture. An IRB/IEC approved PEAK participant invitation process and participant&#xD;
      self-opt-in registration may be utilized where country regulations and site policies allow.&#xD;
&#xD;
      This Registry, with the appropriate participant (and or parent/guardian) consent/assent, may&#xD;
      incorporate retrospective data from other properly consented studies done for the purpose of&#xD;
      examining the longitudinal natural history of PK deficiency. As necessary, data integration&#xD;
      plan(s) will be developed to allow efficient and fit-for-purpose integration of data from&#xD;
      other studies or data sets into this Registry.&#xD;
&#xD;
      Separate detailed statistical analysis plans (SAPs), addressing specific objectives, will be&#xD;
      developed before the analyses during and at the end of the study. Due to the nature of the&#xD;
      observational study, most statistical analyses will focus on descriptive statistics,&#xD;
      including estimates and confidence intervals (CI) as appropriate. Additional statistical&#xD;
      modeling of the data may be conducted. However, any p-values reported for hypothesis testing&#xD;
      will be considered exploratory and therefore hypothesis-generating by nature. All data will&#xD;
      be analyzed as collected in the database. Missing data, in general, will not be imputed; the&#xD;
      modeling, eg, repeated measures mixed-effect models (MMRM) or generalized linear mixed effect&#xD;
      model (GLIMMIX) will make use of all available data in the analyses. Any additional&#xD;
      imputation techniques, if deemed necessary, will be discussed in the statistical analysis&#xD;
      plan(s).&#xD;
&#xD;
      To ensure compliance with Good Clinical Practice and all applicable regulatory requirements,&#xD;
      the Sponsor and its representatives will conduct and manage several plans that will ensure&#xD;
      quality control. These will include:&#xD;
&#xD;
        -  A documented sourcing procedure for all representatives and technology managing,&#xD;
           collecting, or reporting on Registry data&#xD;
&#xD;
        -  Assurance of FDA 21 CFR Part 11, EU-US Privacy Shield, and equivalent regulations&#xD;
           regarding data security, controls, and audit trail of study data&#xD;
&#xD;
        -  Assurance of the European Union regulation 2016/679 describing the appropriate use of&#xD;
           personal data in scientific research&#xD;
&#xD;
        -  Practices and methods for the protection of all participant privacy in relation to study&#xD;
           data collection&#xD;
&#xD;
        -  A training plan for site initiation and documentation&#xD;
&#xD;
        -  Data entry guidelines that will assist all study sites with the completion of eCRFs&#xD;
&#xD;
        -  A data monitoring and management plan that will outline the processes and procedures for&#xD;
           reviewing, querying, and resolving data quality issues with study sites&#xD;
&#xD;
        -  A site monitoring plan for the Sponsor and its representatives that will outline the&#xD;
           frequency, requirements, and nature of the site monitoring visits for purposes of&#xD;
           insuring data quality.&#xD;
&#xD;
      The Registry will be overseen by a Scientific Steering Committee, comprised of international&#xD;
      experts involved in the research, diagnosis, and/or care of patients with PK deficiency. The&#xD;
      Scientific Steering Committee's activities may include further defining the objectives and&#xD;
      scientific direction of the Registry, advising on additional clinical data to be captured,&#xD;
      and facilitating analysis and dissemination of Registry data via medical conferences and&#xD;
      peer-reviewed publications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 23, 2018</start_date>
  <completion_date type="Anticipated">May 31, 2027</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2027</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Clinical Course of PK Deficiency</measure>
    <time_frame>9 years</time_frame>
    <description>To develop an understanding of the longitudinal clinical implications of PK deficiency, including disease natural history, treatments and outcomes, and variability in clinical care and disease burden.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severity of Disease</measure>
    <time_frame>9 years</time_frame>
    <description>To understand the prevalence, incidence, and severity of complications associated with PK deficiency.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease Impact on Pregnancy</measure>
    <time_frame>9 years</time_frame>
    <description>To evaluate pregnancy outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Management Assistance</measure>
    <time_frame>9 years</time_frame>
    <description>To provide a source of longitudinal data to assist physicians with clinical management of individual patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Repository</measure>
    <time_frame>9 years</time_frame>
    <description>To act as a global repository for potential data from other properly consented PK deficiency-related studies to support aggregate and comparative analyses.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Genetic</measure>
    <time_frame>9 years</time_frame>
    <description>To examine a possible correlation between PKLR genotype and PK deficiency clinical phenotype.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Pyruvate Kinase Deficiency</condition>
  <arm_group>
    <arm_group_label>PKD Diagnosed</arm_group_label>
    <description>Participants diagnosed with PK deficiency by the presence of 2 or more PKLR gene mutations as well as clinical features.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be recruited or referred by physicians who treat hemolytic anemias at&#xD;
        approximately 60 sites in approximately 20 countries.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants of all ages with a confirmed diagnosis of PK deficiency via genetic&#xD;
             testing are eligible to enroll;&#xD;
&#xD;
          -  Participants will be considered for enrollment on the basis of clinical features&#xD;
             consistent with PK deficiency together with the presence of 2 or more PKLR gene&#xD;
             mutations. For novel or indeterminate PKLR gene mutations, participants will be deemed&#xD;
             eligible if, in the opinion of the investigator, the reported PKLR gene mutations are&#xD;
             sufficient to support a diagnosis of PK deficiency;&#xD;
&#xD;
          -  The participant or the parent/guardian of the participant must be willing and able to&#xD;
             give written informed consent and/or assent. E-consent or remote consent may be&#xD;
             utilized where permissible as applicable if country regulations and site policies&#xD;
             allow.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva Gallagher, VP, Medical Affairs</last_name>
    <role>Study Chair</role>
    <affiliation>Agios Pharmaceuticals, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Medical Information</last_name>
    <phone>833-228-8474</phone>
    <email>MedInfo@agios.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Phoenix Childrens Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Arkansas Children's Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Orange County</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Children's Healthcare of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>UMass Memorial Medical Center</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655-0002</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Michigan</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>St Jude Children's Research Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Primary Children's Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84113</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Vermont Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Saint Josephs Healthcare System</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice Olomouc</name>
      <address>
        <city>Olomouc</city>
        <zip>779 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ustav hematologie a krevni transfuze</name>
      <address>
        <city>Praha 2</city>
        <zip>128 20</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice v Motole</name>
      <address>
        <city>Praha 5</city>
        <zip>150 06</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Copenhagen University Hospital</name>
      <address>
        <city>Herlev</city>
        <zip>2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Necker</name>
      <address>
        <city>Paris</city>
        <zip>75743</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Charite - Universitatsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Bielefeld gGmbH</name>
      <address>
        <city>Bielefeld</city>
        <zip>33617</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kinder- und Jugendarztpraxis</name>
      <address>
        <city>Munich</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Wurzburg</name>
      <address>
        <city>Wuerzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>St James's Hospital</name>
      <address>
        <city>Dublin</city>
        <zip>D08 NHY1</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Presidio Ospedaliero di Pescara</name>
      <address>
        <city>Pescara</city>
        <state>Abruzzo</state>
        <zip>65125</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>AOU dell'Universita degli Studi della Campania Luigi Vanvitelli</name>
      <address>
        <city>Napoli</city>
        <state>Campania</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>E O Ospedali Galliera</name>
      <address>
        <city>Genova</city>
        <state>Liguria</state>
        <zip>16128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milano</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>AORN A Cardarelli</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Di Padova</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Ospedale S Eugenio</name>
      <address>
        <city>Roma</city>
        <zip>144</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Catholic University of Korea, Seoul St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3508 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar E Universitario de Coimbra EPE</name>
      <address>
        <city>Coimbra</city>
        <zip>3041-853</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar Lisboa Central- Hospital Dona Estefania</name>
      <address>
        <city>Lisboa</city>
        <zip>1169-045</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar de Vila Nova de Gaia / Espinho E.P.E</name>
      <address>
        <city>Porto</city>
        <zip>4200-072</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Sant Joan de Deu - PIN</name>
      <address>
        <city>Esplugues de Llobregat</city>
        <state>Barcelona</state>
        <zip>08950</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Vall d'Hebron - PPDS</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital de La Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>8041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Infantil Universitario Nino Jesus</name>
      <address>
        <city>Madrid</city>
        <zip>28009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital de Tortosa Verge de la Cinta</name>
      <address>
        <city>Tortosa</city>
        <zip>43500</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <zip>CH 1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Siriraj Hospital Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hacettepe University Medical Faculty</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hammersmith Hospital</name>
      <address>
        <city>London</city>
        <state>London, City Of</state>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kings College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Newcastle Upon Tyne Hospitals NHS Foundation Trust</name>
      <address>
        <city>Newcastle upon Tyne</city>
        <zip>NE1 4LP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Ireland</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Netherlands</country>
    <country>Portugal</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>Thailand</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://PEAKRegistry.com</url>
    <description>Overview of the PEAK Registry</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 22, 2018</study_first_submitted>
  <study_first_submitted_qc>March 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2018</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glycolytic enzymopathy</keyword>
  <keyword>Congenital Nonspherocytic hemolytic anemia (CNSA)</keyword>
  <keyword>PKD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Hemolytic, Congenital Nonspherocytic</mesh_term>
    <mesh_term>Pyruvate Metabolism, Inborn Errors</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

